Clindamycin phosphate 1.2% and tretinoin 0.025% gel for rosacea: Summary of a placebo-controlled, double-blind trial

Journal of Drugs in Dermatology

Volumn 11, Issue 12, 2012, Pages 1410-1414

  Freeman, Scott A ^a   Moon, Summer D ^b   Spencer, James M ^a,c  

^a Spencer Dermatology and Skin Surgery Center   (United States)

^b LAKE ERIE COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN PHOSPHATE PLUS RETINOIC ACID; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FOLLOW UP; HUMAN; PAPULE; PUSTULE; ROSACEA; TREATMENT RESPONSE;

ADMINISTRATION, TOPICAL; ADULT; ANTI-BACTERIAL AGENTS; CLINDAMYCIN; DIAGNOSTIC SELF EVALUATION; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; GELS; HUMANS; IRRITANTS; KERATOLYTIC AGENTS; MALE; MIDDLE AGED; ROSACEA; SKIN; SKIN PIGMENTATION; TRETINOIN; YOUNG ADULT;

EID: 84871089860     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Dahl MV. Pathogenesis of rosacea. Adv Dermatol. 2001;17:29-45.
2. Dahl MV. Optimal strategies for the treatment of rosacea. Skin Aging. 1999;7:44-48.
3. Millikan L. The proposed inflammatory pathophysiology of rosacea: implications for treatment. Skinmed. 2003;2(1):43-47.
4. Wilkin JK. Rosacea. Pathophysiology and treatment. Arch Dermatol. 1994;130(3):359-362.
5. Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol. 2002;46(4):584-587.
6. National Rosacea Society. 14 million Americans have rosacea - and most of them don't know it. http://www.rosacea.org. Accessed September 9, 2003.
7. Kircik LH. Safety and efficacy evaluation of tretinoin cream 0.02% for the reduction of photodamage: a pilot study. J Drugs Dermatol. 2012;11(1):83-90.
8. Nally JB, Berson DS. Topical therapies for rosacea. J Drugs Dermatol. 2006;5(1):23-26.